Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Lifeist Wellness Inc V.LFST

Alternate Symbol(s):  LFSWF

Lifeist Wellness Inc. is a Canada-based health-tech company. The Company leverages advancements in science and technology to develop innovative products to support human wellness and transform lives. The Company's key asset is its United States biosciences subsidiary Mikra Cellular Sciences Inc. (Mikra), a biosciences and consumer wellness company focused on developing and selling products... see more

TSXV:LFST - Post Discussion

Lifeist Wellness Inc > Latest PR about CannMart Labs Dealer's License
View:
Post by QuothTheRaven on Jun 07, 2021 1:33pm

Latest PR about CannMart Labs Dealer's License

That's pretty major.  I didn't even know N was aiming at anything past mushrooms.  But really nice -- the more products the better!

[url=https://ceo.ca/@nasdaq/namaste-technologies-provides-corporate-update-on-cannmart]https://ceo.ca/@nasdaq/namaste-technologies-provides-corporate-update-on-cannmart[/url]
 
"Namaste is pleased to advise that it's wholly owned subsidiary CannMart Labs Inc. has submitted its application for a Health Canada Controlled Drugs and Substances Dealer’s Licence for future storage and distribution of the following controlled substances: psilocybin, psilocin, ketamine, LSD, DMT and MDMA. Projected timeline for receipt of approvals is by the beginning of fiscal third quarter of 2022. Subject to Health Canada acceptance, the Dealer’s Licence will allow Labs to sell these controlled substances to individuals (or their compounding pharmacies), researchers and companies undertaking clinical trials, each retaining appropriate approvals for such possession and use."
Comment by Stalkhouse on Jun 08, 2021 4:19pm
This post has been removed in accordance with Community Policy
Comment by randomtask on Jun 08, 2021 10:17pm
So they are delaying labs for some special niche they've discovered?  Maybe it's the "wellness" market that lying lhama says that namaste is about to invent?!?   You're so smart :) the truth is the company has failed to execute at every level and this will shortly be in the teens again as even the blinded, bad holding longs realize that this company always has ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities